Netherlands· NL-0a1c31f29498

Famotidine Sanias10 mg, tabletten

A famotidine product containing famotidine, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 15 of our 19 countries.

ATC A02BA03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about famotidineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Famotidine is registered in 15 of 19 countries.

Countries holding a registration under ATC A02BA03 (famotidine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search famotidine products by name

Famotidine · ATC A02BA03

15 / 19 countries

Canada
Czechiaprice
Finlandprice
Franceprice
Germany
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of famotidine costs, country by country.

Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.26 in Spain to $0.76 in Italy — a ×3.0 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Famotidine · price per daily dose (40 mg)

USD · FX 28 Sept 2026

IT Italy$0.76
FR France$0.59
ES Spain$0.26

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: FAMOTIDINE
Manufacturer: Aurobindo Pharma B.V.
Country: Netherlands (NL)
ATC code: A02BA03
ATC class: Famotidine
Defined daily dose: 40 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
25579

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

778 interactions on record for famotidine.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check famotidine against other medicines How interaction checks work

Famotidine · interactions on record

778 records

14 severe
277 moderate
52 minor
434 info

Most severe, free to view

AtazanavirJ05AE08severe
RilpivirineJ05AG05severe
DasatinibL01EA02severe
NeratinibL01EH02severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Famotidine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All famotidine products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

Austria · Famosin, Famotidin !$tada
Bulgaria · Famore 20 Mg, Famore 40 Mg
Cyprus · Famopsin, Ulcedine
Czechia · Famosan, Kuladgy
Germany · Famotidin Ratiopharm, Famotidin Stada
Estonia · Kuladgy
Spain · Famotidina Aristo, Famotidina Cinfa
Finland · Pepcid
France · Famotidine Eg, Famotidine Eg Labo
United Kingdom (Northern Ireland) · Famotidine Alissa Healthcare Research, Famotidine Celix Pharma
Greece · Banatin, Famotidine Beλκα Ελλασ
Croatia · Confamo, Famosan
Hungary · Apo-Famotidin, Motidin
Ireland · Famotidine Amdipharm, Famotidine Clonmel
Italy · Famotidina Doc, Famotidina Eg
Lithuania · Kuladgy, Quamatel
Latvia · Kuladgy, Quamatel
Malta · Famotidine Clonmel Healthcare
Norway · Famotidin Vivanta, Pepcid
Poland · Famiflux, Famogast
Portugal · Lasa
Romania · Famodin, Famotidină Zentiva
Sweden · Famotidin Vivanta, Pepcid
Slovakia · Famosan, Famotidin Sl Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/eaa9cfcd-b9cb-4cd8-893e-d7e0d5894878
GET /v1/drugs/eaa9cfcd-b9cb-4cd8-893e-d7e0d5894878?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h25579_smpc.pdf",
  "strength": null,
  "atc_label": "Famotidine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg25579",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "INDIGOKARMIJN (E 132)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT"
  ],
  "substances": [
    "FAMOTIDINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h25579.pdf",
  "authorised_at": "2000/06/19",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "25579",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about famotidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console